Sign in Sign up for free

Last updated: 3 May 2024 at 4:30pm EST

Terrence Kearney Net Worth




The estimated Net Worth of Terrence C Kearney is at least $18.9 Million dollars as of 10 August 2023. Mr. Kearney owns over 10,000 units of Vertex Pharmaceuticals stock worth over $7,850,301 and over the last 13 years he sold VRTX stock worth over $10,489,600. In addition, he makes $542,603 as Independent Director at Vertex Pharmaceuticals.

Mr. Kearney VRTX stock SEC Form 4 insiders trading

Terrence has made over 5 trades of the Vertex Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of VRTX stock worth $1,275,400 on 10 August 2023.

The largest trade he's ever made was exercising 68,125 units of Vertex Pharmaceuticals stock on 27 April 2015 worth over $3,870,863. On average, Terrence trades about 5,139 units every 92 days since 2011. As of 10 August 2023 he still owns at least 16,536 units of Vertex Pharmaceuticals stock.

You can see the complete history of Mr. Kearney stock trades at the bottom of the page.





Terrence Kearney biography

Terrence C. Kearney is Independent Director of Vertex Pharmaceuticals Incorporated. Mr. Kearney served as the Chief Operating Officer of Hospira, Inc., a specialty pharmaceutical and medication delivery company, from April 2006 to January 2011. From April 2004 to April 2006, he served as Hospira’s Senior Vice President, Finance, and Chief Financial Officer, and he served as Acting Chief Financial Officer through August 2006. Mr. Kearney served as Vice President and Treasurer of Abbott Laboratories from 2001 to April 2004. From 1996 to 2001, Mr. Kearney was Divisional Vice President and Controller for Abbott’s International Division. Mr. Kearney serves as a member of the Board of Directors at Acceleron Pharma Inc., a biopharmaceutical company. He served as a member of the Board of Directors of Innovia (formerly known as Theravance, Inc.), a royalty management company, from October 2014 through April 2016, and as member of the Board of Directors of AveXis, Inc., a gene therapy company, from January 2016 until its acquisition in May 2018. Mr. Kearney has been a member of the Board of Directors of Levo Therapeutics, Inc., a biotechnology company focused on developing treatments for Prader-Willi Syndrome, since 2018. He received his B.S. in biology from the University of Illinois and his M.B.A. from the University of Denver.

What is the salary of Terrence Kearney?

As the Independent Director of Vertex Pharmaceuticals, the total compensation of Terrence Kearney at Vertex Pharmaceuticals is $542,603. There are 15 executives at Vertex Pharmaceuticals getting paid more, with Jeffrey Leiden having the highest compensation of $18,790,000.



How old is Terrence Kearney?

Terrence Kearney is 65, he's been the Independent Director of Vertex Pharmaceuticals since 2011. There are 1 older and 22 younger executives at Vertex Pharmaceuticals. The oldest executive at Vertex Pharmaceuticals, Inc. is William Young, 75, who is the Independent Director.

What's Terrence Kearney's mailing address?

Terrence's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.

Insiders trading at Vertex Pharmaceuticals

Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.



What does Vertex Pharmaceuticals do?

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.



What does Vertex Pharmaceuticals's logo look like?

Vertex Pharmaceuticals, Inc. logo

Complete history of Mr. Kearney stock trades at Acceleron Pharma Inc and Vertex Pharmaceuticals

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
10 Aug 2023 VRTX Vertex Pharmaceuticals, Inc. Terrence C Kearney
Director
 Option 10,000 $127.54 $1,275,400
10 Aug 2023
16,536 ↗
31 Oct 2019 VRTX Vertex Pharmaceuticals, Inc. Terrence C Kearney
Director
 Sale 52,448 $200.00 $10,489,600
31 Oct 2019
5,811 ↗
19 May 2015 VRTX Vertex Pharmaceuticals, Inc. Terrence C Kearney
Director
 Option 1,500 $56.99 $85,485
19 May 2015
1,500 ↗
27 Apr 2015 VRTX Vertex Pharmaceuticals, Inc. Terrence C Kearney
Director
 Option 68,125 $56.82 $3,870,863
27 Apr 2015
68,125 ↗
12 Oct 2020 XLRN Acceleron Pharma Inc Terrence C Kearney
Director
 Option 37,500 $28.62 $1,073,250
12 Oct 2020
42,627 ↗


Vertex Pharmaceuticals executives and stock owners

Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: